Cited by 140Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysSignaling Pathways in Disease

Mutations in Fbx4 Inhibit Dimerization of the SCFFbx4 Ligase and Contribute to Cyclin D1 Overexpression in Human Cancer

Open access
Barbash, Olena, Zamfirova, Petia, Lin, Douglas I., Chen, Xiangmei, Yang, Ke, Nakagawa, Hiroshi, Lu, Fengmin, Rustgi, Anil K. +1 more·2008·Cancer Cell

Abstract

SCF(Fbx4) was recently identified as the E3 ligase for cyclin D1. We now describe cell-cycle-dependent phosphorylation and dimerization of Fbx4 that is regulated by GSK3beta and is defective in human cancer. We present data demonstrating that a pathway involving Ras-Akt-GSK3beta controls the temporal phosphorylation and dimerization of the SCF(Fbx4) E3 ligase. Inhibition of Fbx4 activity results in accumulation of nuclear cyclin D1 and oncogenic transformation. The importance of this regulatory pathway for normal cell growth is emphasized by the prevalence of mutations in Fbx4 in human cancer that impair dimerization. Collectively, these data reveal that inactivation of the cyclin D1 E3 ligase likely contributes to cyclin D1 overexpression in a significant fraction of human cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2008.05.017

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cancer, failure of SCF(Fbx4) to dimerize blocks ubiquitination of cyclin D1, leading to cyclin D1 accumulation and transformation.

    “Lack of SCF(Fbx4) dimerization in cancer prevents ubiquitination of its substrate cyclin D1, which contributes to cyclin D1 overexpression and transformation (Barbash et al, 2008).”

    From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Barbash et al, 2008

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Barbash, O., Zamfirova, P., Lin, D. I., Chen, X., Yang, K., Nakagawa, H., Lu, F., Rustgi, A. K., & Diehl, J. A.
Affiliations
  • University of Pennsylvania (US)
  • Peking University (CN)
Corresponding author
Diehl, J. Alan
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2008-07
Volume
14
Issue
1
Pages
68-78
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2023040745
Cited by
140
References
39
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 1 · 2020: 6 · 2019: 10 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 15
FWCI
6.03
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (P01CA098101, CA11360, R01CA111360, P30CA016520)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
E3 ubiquitin ligase, cyclin D1, cyclin D1 overexpression, protein dimerization, GSK3β, oncogenic transformation, human cancer
MeSH terms
Glycogen Synthase Kinase 3 beta, Animals, Cell Cycle, Cell Nucleus, Cell Transformation, Neoplastic, Esophageal Neoplasms, Female, Humans, Mammary Neoplasms, Experimental, Mutation, Phosphorylation, Serine, Transfection, Up-Regulation, Gene Expression Regulation, Neoplastic, Cyclins, Mice, SCID, Mice, Inbred NOD, Protein Structure, Tertiary, ras Proteins, Dimerization, Glycogen Synthase Kinase 3, NIH 3T3 Cells, F-Box Proteins, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Mice, Cyclin D

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review